JNJ Performance & Benchmarks - 7.5% in 12m
The Total Return for 3m is 9.3%, for 6m 12% and YTD 17.6%. Compare with Peer-Group: Pharmaceuticals
Performance Rating
24.34%
#41 in Peer-Group
Rel. Strength
54.70%
#3483 in Stock-Universe
Total Return 12m
7.48%
#56 in Peer-Group
Total Return 5y
30.88%
#45 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 17.8 |
| P/E Forward | 15.5 |
| High / Low | USD |
|---|---|
| 52 Week High | 169.56 USD |
| 52 Week Low | 139.74 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 76.17 |
| Buy/Sell Signal +-5 | 1.95 |
| Support / Resistance | Levels |
|---|---|
| Support | 164.2, 160.6, 157.9, 155.5, 152.9, 150.2, 143.3 |
| Resistance |
12m Total Return: JNJ (7.5%) vs XLV (-11.8%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Short Term Performance
| Symbol | 1w | 1m | 3m |
|---|---|---|---|
| JNJ | -0.58% | 7.32% | 9.26% |
| SCLX | 12.1% | 122% | 163% |
| NMRA | -33.6% | 96.0% | 102% |
| KALA | -7.29% | 55.0% | 102% |
Long Term Performance
| Symbol | 6m | 12m | 5y |
|---|---|---|---|
| JNJ | 12% | 7.48% | 30.9% |
| VRNA | 78.3% | 365% | 1,479% |
| AMLX | 126% | 273% | -57.3% |
| ALTS | 3.80% | 303% | 48.8% |
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-0.45% | 81.9% | 350% | 58.4 | 54.6 | 0.61 | 32.2% | -1.12% |
| NVS NYSE Novartis |
-6.34% | 6.56% | 78.4% | 17.1 | 13.3 | 1.28 | 58.9% | - |
| LLY NYSE Eli Lilly |
-1.75% | -7.8% | 429% | 65.5 | 36.6 | 1.23 | 61.9% | 42.8% |
| NOVN SW Novartis |
-3.79% | 0.98% | 56.8% | 17.3 | 13.3 | 1.27 | 63.7% | 33.2% |
| GSK NYSE GlaxoSmithKline |
-3.57% | -1.07% | 43% | 17.6 | 8.89 | 0.39 | -13.7% | 23.9% |
| AZN NASDAQ AstraZeneca |
3.48% | -7.09% | 46% | 28.9 | 16 | 0.96 | 61.2% | 98.6% |
| SOBI ST Swedish Orphan Biovitrum |
-7.29% | -4.89% | 47.4% | 22.3 | 20 | 1.84 | 19.8% | 42.6% |
| ZEG XETRA AstraZeneca |
6.04% | -12.4% | 45.7% | 29 | 16.7 | 1 | 60.5% | 101% |
Performance Comparison: JNJ vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for JNJ
| Total Return (including Dividends) | JNJ | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 7.32% | -4.08% | 0.66% |
| 3 Months | 9.26% | -3.57% | 11.66% |
| 12 Months | 7.48% | -11.78% | 15.92% |
| 5 Years | 30.88% | 33.11% | 103.09% |
| Trend Stabilty (consistency of price movement) | JNJ | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 80.5% | -29.7% | 66.4% |
| 3 Months | 70.9% | 25% | 96.6% |
| 12 Months | 0.4% | -83% | 50% |
| 5 Years | 35.8% | 86.9% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | 71 %th | 11.88% | 6.62% |
| 3 Month | 61 %th | 13.31% | -2.15% |
| 12 Month | 74 %th | 21.82% | -7.29% |
| 5 Years | 76 %th | -1.68% | -35.56% |
FAQs
Does Johnson & Johnson (JNJ) outperform the market?
Yes,
over the last 12 months JNJ made 7.48%, while its related Sector, the Health Care Sector SPDR (XLV) made -11.78%.
Over the last 3 months JNJ made 9.26%, while XLV made -3.57%.
Performance Comparison JNJ vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
JNJ vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 1.8% | 6.7% | 7.4% | -8% |
| US NASDAQ 100 | QQQ | 1.6% | 6.1% | 4.8% | -14% |
| German DAX 40 | DAX | 2.7% | 8.4% | 3.1% | -21% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 2% | 4.6% | 3.1% | -14% |
| Hongkong Hang Seng | HSI | 1.6% | 5.2% | -15.3% | -32% |
| India NIFTY 50 | INDA | 1.4% | 12.9% | 8.4% | 14% |
| Brasil Bovespa | EWZ | 0.5% | 14.8% | 5.1% | 4% |
JNJ vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 0.8% | 8.8% | 8% | -17% |
| Consumer Discretionary | XLY | 3.3% | 8.3% | 17.2% | -12% |
| Consumer Staples | XLP | 1.1% | 9.5% | 9.7% | 3% |
| Energy | XLE | 1.2% | 7.2% | 13.4% | 10% |
| Financial | XLF | 3.2% | 9.7% | 11% | -14% |
| Health Care | XLV | 3.3% | 11.4% | 22.3% | 19% |
| Industrial | XLI | 2.8% | 6.2% | 2% | -14% |
| Materials | XLB | 5.5% | 11.1% | 13.5% | 11% |
| Real Estate | XLRE | 2.9% | 8.3% | 10.6% | 5% |
| Technology | XLK | 1.3% | 4.9% | -1.3% | -15% |
| Utilities | XLU | -2.1% | 2.6% | 0.9% | -12% |
| Aerospace & Defense | XAR | 2.2% | 3.2% | -10.8% | -38% |
| Biotech | XBI | 1.3% | 3.9% | 18% | 20% |
| Homebuilder | XHB | 1.9% | 6.2% | 13.3% | 16% |
| Retail | XRT | 4.2% | 9.3% | 12.7% | 4% |
JNJ vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -4.1% | 2.55% | 12.5% | 6% |
| Natural Gas | UNG | 0.9% | 17.2% | 34.8% | 3% |
| Gold | GLD | -1.1% | 6.8% | -6.9% | -29% |
| Silver | SLV | 2.5% | 4.7% | -5.2% | -22% |
| Copper | CPER | 22.5% | 20% | 10.5% | -1% |
JNJ vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -2.2% | 7.7% | 10.6% | 12% |
| iShares High Yield Corp. Bond | HYG | 0.1% | 7.6% | 8.6% | -1% |